Progenitor cells from cartilage-No osteoarthritis-grade-specific differences in stem cell marker expression

Biotechnology Progress

Volumn 29, Issue 1, 2013, Pages 206-212

  Bernstein, Peter ^a   Sperling, Ines ^a   Corbeil, Denis ^b   Hempel, Ute ^b   Fickert, Stefan ^c,d  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c Sporthopaedicum Straubing   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chondrogenic progenitors; Dedifferentiation; Mesenchymal stromal cell; Osteoarthritis; Surface markers

Indexed keywords

CHONDROGENIC; DEDIFFERENTIATION; MESENCHYMAL STROMAL CELLS; OSTEOARTHRITIS; SURFACE MARKERS;

AUTOMOBILE MANUFACTURE; BODY FLUIDS; CARTILAGE; CELL MEMBRANES; FLOW CYTOMETRY; MONOLAYERS; PHOSPHATASES; STEM CELLS; TISSUE ENGINEERING;

CELL CULTURE;

BIOLOGICAL MARKER;

AGED; ARTICLE; BONE DEVELOPMENT; CARTILAGE; CELL CULTURE; CELL DIFFERENTIATION; CULTURE TECHNIQUE; CYTOLOGY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; PHENOTYPE; STEM CELL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARTILAGE; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; OSTEOGENESIS; PHENOTYPE; STEM CELLS;

EID: 84873291749     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1668     Document Type: Article

References (31)

1. Mollenhauer JA. Perspectives on articular cartilage biology and osteoarthritis. Injury. 2008; 39(Suppl 1): S5-12.
2. Pelttari K, Steck E, Richter W. The use of mesenchymal stem cells for chondrogenesis. Injury. 2008; 39(Suppl 1): S58-65.
3. Haasper C, Zeichen J, Meister R, Krettek C, Jagodzinski M. Tissue engineering of osteochondral constructs in vitro using bioreactors. Injury. 2008; 39(Suppl 1): S66-76.
4. Nesic D, Whiteside R, Brittberg M, Wendt D, Martin I, Mainil-Varlet P. Cartilage tissue engineering for degenerative joint disease. Adv Drug Deliv Rev. 2006; 58: 300-322.
5. Ahmed TA, Hincke MT. Strategies for articular cartilage lesion repair and functional restoration. Tissue Eng Part B Rev. 2010; 16: 305-329.
6. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells. 2001; 19: 180-192.
7. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-147.
8. Bernstein P, Sticht C, Jacobi A, Liebers C, Manthey S, Stiehler M. Expression pattern differences between osteoarthritic chondrocytes and mesenchymal stem cells during chondrogenic differentiation. Osteoarthritis Cartilage. 2010; 18: 1596-1607.
9. Darling EM, Athanasiou KA. Rapid phenotypic changes in passaged articular chondrocyte subpopulations. J Orthop Res. 2005; 23: 425-432.
10. Diaz-Romero J, Gaillard JP, Grogan SP, Nesic D, Trub T, Mainil-Varlet P. Immunophenotypic analysis of human articular chondrocytes: changes in surface markers associated with cell expansion in monolayer culture. J Cell Phys. 2005; 202: 731-742.
11. Alsalameh S, Amin R, Gemba T, Lotz M. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum. 2004; 50: 1522-1532.
12. Hiraoka K, Grogan S, Olee T, Lotz M. Mesenchymal progenitor cells in adult human articular cartilage. Biorheology. 2006; 43: 447-454.
13. Grogan SP, Miyaki S, Asahara H, D'Lima DD, Lotz MK. Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritis. Arthitis Res Ther. 2009; 11: R85.
14. Fickert S, Fiedler J, Brenner RE. Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers. Arthritis Res Ther. 2004; 6: 422-432.
15. Outerbridge RE. The etiology of chondromalacia patellae. J Bone Joint Surg Br. 1961; 43-B: 752-757.
16. Freshney I. Application of cell cultures to toxicology. Cell Biol Toxicol. 2001; 17: 213-230.
17. Bernstein P, Dong M, Corbeil D, Gelinsky M, Günther K-P, Fickert S. Pellet culture elicits superior chondrogenic redifferentiation than alginate-based systems. Biotechnol Prog. 2008; 25: 1146-1152.
18. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta. 1986; 883: 173-177.
19. Enobakhare BO, Bader DL, Lee DA. Quantification of sulfated glycosaminoglycans in chondrocyte/alginate cultures by use of 1, 9-dimethylmethylene blue. Anal Biochem. 1996; 243: 189-191.
20. Brunk CF, Jones KC, James TW. Assay for nanogram quantities of DNA in cellular homogenates. Anal Biochem. 1979; 92: 497-500.
21. Chen XD, Qian HY, Neff L, Satomura K, Horowitz MC. Thy-1 antigen expression by cells in the osteoblast lineage. J Bone Miner Res. 1999; 14: 362-375.
22. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, Deans RJ, Keating A, Prockop DJ, Horwitz EM. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 315-317.
23. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004; 36: 568-584.
24. Najar M, Raicevic G, Id Boufker H, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L. Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. Exp Hematol. 2010; 38: 922-932.
25. Ren G, Zhao X, Zhang L, Zhang J, L'Huillier A, Ling W, Roberts AI, Le AD, Shi S, Shao C, Shi Y. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol. 2010; 184: 2321-2328.
26. Pham PV, Phan NL, Nguyen NT, Truong NH, Duong TT, Le DV, Truong KD, Phan NK. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy. J Transl Med. 2011; 9: 209.
27. Fickert S, Schroter-Bobsin U, Gross AF, Hempel U, Wojciechowski C, Rentsch C, Corbeil D, Gunther KP. Human mesenchymal stem cell proliferation and osteogenic differentiation during long-term ex vivo cultivation is not age dependent. J Bone Miner Metab. 2011; 29: 224-235.
28. Kim MJ, Son MJ, Son MY, Seol B, Kim J, Park J, Kim JH, Kim YH, Park SA, Lee CH, Lee KS, Han YM, Chang JS, Cho YS. Generation of human induced pluripotent stem cells from osteoarthritis patient-derived synovial cells. Arthritis Rheum. 2011; 63: 3010-3021.
29. Steinert AF, Kunz M, Prager P, Barthel T, Jakob F, Noth U, Murray MM, Evans CH, Porter RM. Mesenchymal stem cell characteristics of human anterior cruciate ligament outgrowth cells. Tissue Eng Part A. 2011; 17: 1375-1388.
30. Yin J, Yang Z, Cao YP, Ge ZG. Characterization of human primary chondrocytes of osteoarthritic cartilage at varying severity. Chin Med J (Engl). 2011; 124: 4245-4253.
31. Mauney JR, Kirker-Head C, Abrahamson L, Gronowicz G, Volloch V, Kaplan DL. Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. J Biomed Mater Res. 2006; 79A: 464-475.